Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

BACKGROUND: Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcomes of IN...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanowski, Kamila, Chiang, Leslie Y., Roth, David Z., Krajden, Mel, Tang, Patrick, Cook, Victoria J., Johnston, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583994/
https://www.ncbi.nlm.nih.gov/pubmed/28870175
http://dx.doi.org/10.1186/s12879-017-2706-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583994/
https://www.ncbi.nlm.nih.gov/pubmed/28870175
http://dx.doi.org/10.1186/s12879-017-2706-0

Ejemplares similares